AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Acquiring Company
Telix Pharmaceuticals Limited
Acquired Company
ITM Isotope Technologies Munich SE
Melbourne
MunichBiotechnologyManufacturingHealth CareDescription
Telix Pharmaceuticals is merging with ITM Isotope Technologies Munich SE in a significant deal worth at least $1.65 billion. Under the agreement, Telix will acquire all shares of ITM and may pay an additional $700 million based on performance criteria. This merger will strengthen Telix's position in the rapidly growing radiopharmaceuticals market. The combined entity aims to enhance cancer treatment options through innovative therapies.
Fundz sees it the moment Telix Pharmaceuticals Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired ITM Isotope Technologies Munich SE?
ITM Isotope Technologies Munich SE was acquired by Telix Pharmaceuticals Limited, based in Melbourne. The deal was reported on September 20, 2026. Telix Pharmaceuticals Limited (ASX: TLX) is a leading pharmaceutical company specializing in advanced diagnostic and therapeutic radiopharmaceuticals. Telix Pharmaceuticals Limited is publicly traded (TLX) and operates in Biotechnology.
When did Telix Pharmaceuticals Limited acquire ITM Isotope Technologies Munich SE?
Telix Pharmaceuticals Limited's acquisition of ITM Isotope Technologies Munich SE was reported on September 20, 2026. Telix Pharmaceuticals is merging with ITM Isotope Technologies Munich SE in a significant deal worth at least $1.65 billion. Under the agreement, Telix will acquire all shares of ITM and may pay an additional $700 million based on performance criteria. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ITM Isotope Technologies Munich SE do?
www.itm-radiopharma.com. It is privately held, operating in Manufacturing, and is based in Munich.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.